{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T23:13:33Z","timestamp":1794611613317,"version":"4.9.1"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,16]],"date-time":"2024-04-16T00:00:00Z","timestamp":1713225600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics &amp; Gynecology and Reproductive Biology: X"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.eurox.2024.100307","type":"journal-article","created":{"date-parts":[[2024,4,26]],"date-time":"2024-04-26T03:32:40Z","timestamp":1714102360000},"page":"100307","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Association between the use of oral contraceptives and the occurrence of systemic hypertension: A systematic review with statistical comparison between randomized clinical trial interventions"],"prefix":"10.1016","volume":"22","author":[{"given":"Ingrid Soares","family":"de Souza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel Zorello","family":"Laporta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliana","family":"Zangirolami-Raimundo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel Cristina Esposito","family":"Sorpreso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heloisa Carla Lopes","family":"Silva dos Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Maria","family":"Soares J\u00fanior","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo Daminello","family":"Raimundo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"24","key":"10.1016\/j.eurox.2024.100307_bib1","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1001\/jama.2021.21392","article-title":"Contraception selection, effectiveness, and adverse effects: a review","volume":"326","author":"Teal","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.eurox.2024.100307_bib2","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1016\/S0140-6736(12)62204-1","article-title":"National, regional, and global rates and trends in contraceptive prevalence and unmet need for family planning between 1990 and 2015: a systematic and comprehensive analysis","volume":"381","author":"Alkema","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.eurox.2024.100307_bib3","doi-asserted-by":"crossref","first-page":"h2135","DOI":"10.1136\/bmj.h2135","article-title":"Use of combined oral contraceptives and risk of venous thromboembolism: nested case-control studies using the QResearch and CPRD databases","volume":"v. 350","author":"Vinogradova","year":"2015","journal-title":"BMJ"},{"issue":"4","key":"10.1016\/j.eurox.2024.100307_bib4","doi-asserted-by":"crossref","first-page":"e81","DOI":"10.1590\/S0066-782X2011005000022","article-title":"Hormonal contraception and cardiovascular system","volume":"96","author":"Brito","year":"2011","journal-title":"Arq Bras Cardiol [Internet]"},{"issue":"5","key":"10.1016\/j.eurox.2024.100307_bib5","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1093\/ije\/dyw147","article-title":"Effects of hormonal contraception on systemic metabolism: cross-sectional and longitudinal evidence","volume":"45","author":"Wang","year":"2016","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.eurox.2024.100307_bib6","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1590\/1980-5497201600010004","article-title":"Hypertension prevalence and associated factors in men and women living in cities of the Legal Amazon","volume":"v. 19","author":"Silva","year":"2016","journal-title":"Rev Bras De Epidemiol"},{"issue":"7","key":"10.1016\/j.eurox.2024.100307_bib7","doi-asserted-by":"crossref","first-page":"3863","DOI":"10.1210\/jc.2004-1958","article-title":"Association between the current use of low-dose oral contraceptives and cardiovascular arterial disease: a meta-analysis","volume":"90","author":"Baillargeon","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"issue":"24","key":"10.1016\/j.eurox.2024.100307_bib8","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1056\/NEJMoa1111840","article-title":"Thrombotic stroke and myocardial infarction with hormonal contraception","volume":"366","author":"Lidegaard","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eurox.2024.100307_bib9","unstructured":"World Health Organization. WHO Library Cataloguing-in-Publication Data. Medical eligibility criteria for contraceptive use - 5th ed. ISBN 978 92 4 154915 8. \u3008https:\/\/www.who.int\/publications\/i\/item\/9789241549158\u3009."},{"issue":"1","key":"10.1016\/j.eurox.2024.100307_bib10","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s13643-021-01626-4","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"10","author":"Page","year":"2021","journal-title":"Syst Rev"},{"key":"10.1016\/j.eurox.2024.100307_bib11","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s13643-016-0384-4","article-title":"Rayyan \u2014 a web and mobile app for systematic reviews","volume":"5","author":"Ouzzani","year":"2016","journal-title":"Syst Rev"},{"key":"10.1016\/j.eurox.2024.100307_bib12","unstructured":"Higgins\u00a0J.P.T.\u00a0,\u00a0Eldridge\u00a0S.\u00a0,\u00a0Li\u00a0T.\u00a0(editors). Chapter 23: Including Variants on Randomized Trials. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.4 (updated August 2023). Cochrane,\u00a02023. Available from\u00a0\u3008www.training.cochrane.org\/handbook\u3009."},{"key":"10.1016\/j.eurox.2024.100307_bib13","doi-asserted-by":"crossref","unstructured":"Sch\u00fcnemann\u00a0H J,\u00a0Oxman\u00a0A D,\u00a0Brozek\u00a0J,\u00a0Glasziou\u00a0P,\u00a0Jaeschke\u00a0R,\u00a0Vist\u00a0G\u00a0E\u00a0et al.,Grading Quality of Evidence and Strength of Recommendations for Diagnostic Tests and Strategies. BMJ. 2008 May 17;336(7653):1106\u201310. doi: 10.1136\/bmj.39500.677199.AE. Erratum in: BMJ. 2008 May 24;336(7654). doi: 10.1136\/bmj.a139. Sch\u00fcnemann, A Holger J [corrected to Sch\u00fcnemann, Holger J]. PMID: 18483053; PMCID: PMC2386626.","DOI":"10.1136\/bmj.39500.677199.AE"},{"key":"10.1016\/j.eurox.2024.100307_bib14","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/1471-2458-14-28","article-title":"Efficacy of a text messaging (SMS) based intervention for adults with hypertension: protocol for the StAR (SMS Text-message Adherence suppoRt trial) randomised controlled trial","volume":"14","author":"Bobrow","year":"2014","journal-title":"BMC Public Health"},{"issue":"8693","key":"10.1016\/j.eurox.2024.100307_bib15","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/0140-6736(90)90944-Z","article-title":"Blood pressure, stroke, and coronary heart disease. Part 2, Short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context","volume":"335","author":"Collins","year":"1990","journal-title":"Lancet"},{"issue":"35","key":"10.1016\/j.eurox.2024.100307_bib16","first-page":"24","article-title":"Mean systolic and diastolic blood pressure in adults aged 18 and over in the United States, 2001-2008","volume":"1-22","author":"Wright","year":"2011","journal-title":"Natl Health Stat Rep"},{"issue":"3","key":"10.1016\/j.eurox.2024.100307_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1004188","article-title":"Combined and progestagen-only hormonal contraceptives and breast cancer risk: a UK nested case-control study and meta-analysis","volume":"20","author":"Fitzpatrick","year":"2023","journal-title":"PLoS Med"},{"key":"10.1016\/j.eurox.2024.100307_bib18","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2023.1127104","article-title":"Investigating cardiovascular risk in premenopausal women on oral contraceptives: systematic review with meta-analysis","volume":"10","author":"Fabunmi","year":"2023","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.eurox.2024.100307_bib19","doi-asserted-by":"crossref","first-page":"R33","DOI":"10.1152\/ajpregu.00338.2003","article-title":"Gender, sex hormones, and vascular tone","volume":"286","author":"Orshal","year":"2004","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/j.eurox.2024.100307_bib20","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1055\/s-0042-1745790","article-title":"Renin-angiotensin-aldosterone system in women using combined oral contraceptive: a systematic review","volume":"44","author":"Dos Santos","year":"2022","journal-title":"Rev Bras Ginecol Obstet"},{"key":"10.1016\/j.eurox.2024.100307_bib21","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1161\/01.HYP.35.1.155","article-title":"Role of the angiotensin type 2 receptor in the regulation of blood pressure and renal function","volume":"35","author":"Carey","year":"2000","journal-title":"Hypertension"},{"key":"10.1016\/j.eurox.2024.100307_bib22","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1590\/0034-7167-2017-0317","article-title":"Effects of different hormonal contraceptives in women\u2019s blood pressure values","volume":"71","author":"Ribeiro","year":"2018","journal-title":"Rev Bras Enferm"},{"issue":"4","key":"10.1016\/j.eurox.2024.100307_bib23","doi-asserted-by":"crossref","first-page":"H2009","DOI":"10.1152\/ajpheart.00522.2007","article-title":"Renin-angiotensin-aldosterone system and oxidative stress in cardiovascular insulin resistance","volume":"293","author":"Cooper","year":"2007","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"4","key":"10.1016\/j.eurox.2024.100307_bib24","doi-asserted-by":"crossref","first-page":"H1770","DOI":"10.1152\/ajpheart.01011.2005","article-title":"Estrogen receptor-alpha mediates estrogen protection from angiotensin II-induced hypertension in conscious female mice","volume":"292","author":"Xue","year":"2007","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"4","key":"10.1016\/j.eurox.2024.100307_bib25","doi-asserted-by":"crossref","first-page":"H925","DOI":"10.1152\/ajpheart.00188.2018","article-title":"Blood pressure predicts endothelial function and the effects of ethinyl estradiol exposure in young women","volume":"315","author":"Adler","year":"2018","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.eurox.2024.100307_bib26","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ejogrb.2014.01.006","article-title":"Effects of a contraceptive containing drospirenone and ethinyl estradiol on blood pressure and autonomic tone: a prospective controlled clinical trial","volume":"175","author":"Nisenbaum","year":"2014","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.eurox.2024.100307_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.conx.2020.100020","article-title":"A 1-year prospective, open-label, single-arm, multicenter, phase 3 trial of the contraceptive efficacy and safety of the oral progestin-only pill drospirenone 4 mg using a 24\/4-day regimen","volume":"2","author":"Kimble","year":"2020","journal-title":"Contracept X"},{"key":"10.1016\/j.eurox.2024.100307_bib28","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1097\/AOG.0b013e318257217a","article-title":"Continuous compared with cyclic oral contraceptives for the treatment of primary dysmenorrhea: a randomized controlled trial","volume":"119","author":"Dmitrovic","year":"2012","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.eurox.2024.100307_bib29","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.contraception.2012.09.023","article-title":"Effects of combined oral contraceptives containing levonorgestrel or chlormadinone on the endothelium","volume":"87","author":"Franceschini","year":"2013","journal-title":"Contraception"},{"key":"10.1016\/j.eurox.2024.100307_bib30","doi-asserted-by":"crossref","first-page":"396","DOI":"10.3109\/09513590.2015.1006187","article-title":"Comparison of the effects of chlormadinone acetate versus drospirenone containing oral contraceptives on metabolic and hormonal parameters in women with PCOS for a period of two-year follow-up","volume":"31","author":"Yildizhan","year":"2015","journal-title":"Gynecol Endocrinol"},{"issue":"6","key":"10.1016\/j.eurox.2024.100307_bib31","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.orcp.2017.06.001","article-title":"Cardiovascular risk markers among obese women using the levonorgestrel-releasing intrauterine system: A randomised controlled trial","volume":"11","author":"Zueff","year":"2017","journal-title":"Obes Res Clin Pr"},{"issue":"2","key":"10.1016\/j.eurox.2024.100307_bib32","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s00404-008-0907-x","article-title":"Effects of two combined oral contraceptives containing ethinyl estradiol 30 microg combined with either gestodene or drospirenone on hemostatic parameters, lipid profiles and blood pressure","volume":"280","author":"Yildizhan","year":"2009","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.eurox.2024.100307_bib33","doi-asserted-by":"crossref","first-page":"430","DOI":"10.3109\/13625187.2011.614029","article-title":"Efficacy and tolerability of a monophasic combined oral contraceptive containing nomegestrol acetate and 17\u03b2-oestradiol in a 24\/4 regimen, in comparison to an oral contraceptive containing ethinylestradiol and drospirenone in a 21\/7 regimen","volume":"16","author":"Mansour","year":"2011","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.eurox.2024.100307_bib34","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.contraception.2016.06.010","article-title":"Impact of estrogen type on cardiovascular safety of combined oral contraceptives","volume":"94","author":"Dinger","year":"2016","journal-title":"Contraception"},{"key":"10.1016\/j.eurox.2024.100307_bib35","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1111\/jch.13042","article-title":"Association between duration of oral contraceptive use and risk of hypertension: a meta-analysis","volume":"19","author":"Liu","year":"2017","journal-title":"J Clin Hypertens"},{"issue":"2","key":"10.1016\/j.eurox.2024.100307_bib36","doi-asserted-by":"crossref","first-page":"e227","DOI":"10.1016\/S2214-109X(18)30481-9","article-title":"Contraceptive use in Latin America and the Caribbean with a focus on long-acting reversible contraceptives: prevalence and inequalities in 23 countries","volume":"7","author":"Ponce de Leon","year":"2019","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.eurox.2024.100307_bib37","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1590\/S0102-311X2000000200008","article-title":"Women and contraception: knowledge and use of contraceptive methods","volume":"16","author":"Schor","year":"2000","journal-title":"Cad De Sa\u00fade P\u00fablica"},{"issue":"7","key":"10.1016\/j.eurox.2024.100307_bib38","first-page":"48","author":"Manuilova","year":"1989","journal-title":"Akush Ginekol (Mosk)"},{"issue":"77","key":"10.1016\/j.eurox.2024.100307_bib39","doi-asserted-by":"crossref","first-page":"34628","DOI":"10.18632\/oncotarget.26015","article-title":"The clinical relevance of progestogens in hormonal contraception: present status and future developments","volume":"9","author":"Regidor","year":"2018","journal-title":"Oncotarget"}],"container-title":["European Journal of Obstetrics &amp; Gynecology and Reproductive Biology: X"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590161324000279?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590161324000279?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,16]],"date-time":"2024-06-16T22:29:56Z","timestamp":1718576996000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590161324000279"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":39,"alternative-id":["S2590161324000279"],"URL":"https:\/\/doi.org\/10.1016\/j.eurox.2024.100307","relation":{},"ISSN":["2590-1613"],"issn-type":[{"value":"2590-1613","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association between the use of oral contraceptives and the occurrence of systemic hypertension: A systematic review with statistical comparison between randomized clinical trial interventions","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology: X","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eurox.2024.100307","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100307"}}